Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VUTRISIRAN vs VX-950: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

VUTRISIRAN vs VX-950: Safety Overview

Metric VUTRISIRAN VX-950
Total FAERS Reports 1,425 530
Deaths Reported 321 12
Death Rate 22.5% 2.3%
Hospitalizations 550 199
Average Patient Age 72.2 yrs 57.1 yrs
% Female Patients 31.3% N/A
FDA Approval Date Jun 13, 2022 N/A
Manufacturer Alnylam Pharmaceuticals, Inc. N/A
Route SUBCUTANEOUS N/A
Marketing Status Prescription N/A